Dispensaries and Medical Marijuana Certifications and Indications: Unveiling the Geographic Connections in Pennsylvania, USA
- PMID: 38487377
- PMCID: PMC10939510
- DOI: 10.1159/000537841
Dispensaries and Medical Marijuana Certifications and Indications: Unveiling the Geographic Connections in Pennsylvania, USA
Abstract
Introduction: Pennsylvania opened its first medical marijuana (MMJ) dispensary in 2018. Qualifying conditions include six conditions determined to have no or insufficient evidence to support or refute MMJ effectiveness. We conducted a study to describe MMJ dispensary access in Pennsylvania and to determine whether dispensary proximity was associated with MMJ certifications and community demographics.
Methods: Using data from the Pennsylvania Department of Health, we geocoded MMJ dispensary locations and linked them to US Census Bureau data. We created dispensary access measures from the population-weighted centroid of Zip Code Tabulation Areas (ZCTAs): distance to nearest dispensary and density of dispensaries within a 15-min drive. We evaluated associations between dispensary access and the proportion of adults who received MMJ certification and the proportion of certifications for low evidence conditions (amyotrophic lateral sclerosis, epilepsy, glaucoma, Huntington's disease, opioid use disorder, and Parkinson's disease) using negative binomial modeling, adjusting for community features. To evaluate associations racial and ethnic composition of communities and distance to nearest dispensary, we used logistic regression to estimate the odds ratios (OR) and 95% confidence intervals (CI), adjusting for median income.
Results: Distance and density of MMJ dispensaries were associated with the proportion of the ZCTA population certified and the proportion of certifications for insufficient evidence conditions. Compared to ZCTAs with no dispensary within 15 min, the proportion of adults certified increased by up to 31% and the proportion of certifications for insufficient evidence decreased by up to 22% for ZCTAs with two dispensaries. From 2018 to 2021, the odds of being within five miles of a dispensary was up to 20 times higher in ZCTAs with the highest proportions of individuals who were not White (2019: OR: 20.14, CI: 10.7-37.8) and more than double in ZCTAs with the highest proportion of Hispanic individuals (2018: OR: 2.81, CI: 1.51-5.24), compared to ZCTAs with the lowest proportions.
Conclusions: Greater dispensary access was associated with the proportions of certified residents and certifications for low evidence conditions. Whether these patterns are due to differences in accessibility or demand is unknown. Associations between community demographics and dispensary proximity may indicate MMJ access differences.
Keywords: Dispensary; Evidence-based medicine; Geospatial; Marijuana; Medical cannabis.
© 2024 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Geographic proximity to specialized pediatric neurosurgical care in the contiguous United States.J Neurosurg Pediatr. 2018 Apr;21(4):434-438. doi: 10.3171/2017.9.PEDS17436. Epub 2018 Jan 19. J Neurosurg Pediatr. 2018. PMID: 29350592
-
Demographics, Perceptions, and Use of Medical Marijuana among Patients in Florida.Med Cannabis Cannabinoids. 2020 Dec 22;4(1):13-20. doi: 10.1159/000512342. eCollection 2021 Jun. Med Cannabis Cannabinoids. 2020. PMID: 34676347 Free PMC article.
-
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication.JAMA Netw Open. 2020 Jul 1;3(7):e2010001. doi: 10.1001/jamanetworkopen.2020.10001. JAMA Netw Open. 2020. PMID: 32662844 Free PMC article.
-
Examination of Market Segmentation among Medical Marijuana Dispensaries.Subst Use Misuse. 2018 Jul 29;53(9):1463-1467. doi: 10.1080/10826084.2017.1413391. Epub 2018 Jan 5. Subst Use Misuse. 2018. PMID: 29303392 Free PMC article.
-
Geographic variation in availability of opioid treatment programs across U.S. communities.J Addict Dis. 2024 Apr-Jun;42(2):136-146. doi: 10.1080/10550887.2023.2165869. Epub 2023 Jan 16. J Addict Dis. 2024. PMID: 36645315
References
-
- National conference of state legislatures . Medical uses of cannabis. 2023. Available from: https://www.ncsl.org/health/state-medical-cannabis-laws#:∼:text=Medical%... [accessed August 2023].
-
- National Academies of Sciences, Engineering, and medicine . The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources